Fewer Discontinuations With Infliximab for UC Maintenance Tx

Researchers compared the rates of discontinuation after 1 year due to lack of efficacy.

Related Keywords

United States , Leuven , Region Flamande , Belgium , Chicago , Illinois , Colorado , Marc Ferrante , Joshuam Steinberg , University Of Colorado School Medicine , University Hospitals Leuven , Medscape Medical , Digestive Disease Week , Colorado School , Disease Week , Ulcerative Colitis , Biologic Therapy , Monoclonal Antibody , Etuximab , Ituximab , Biosimilars , Biosimilar Drugs , Follow On Biologics , Inflammatory Bowel Disease , Nflammatory Bowel Disease Ibd , Bd , Anti Tnf , Anti Tumor Necrosis Factor , Clinical Research , Clinical Trials , Linical Studies , Colitis , Health Care Economics , Conomics , Meta Analysis , Receptors , Tumor , Social Determinants Of Health ,